Dr. D. Lansing Taylor spoke at the MPS World Summit on Friday, June 3rd, 2022 in New Orleans:  “A Complete Platform for Preclinical Trials of Non-Alcoholic Fatty Liver Disease Including a Patient Specific, Human, Biomimetic Liver Microphysiology System and a Portal to the BioSystics, Inc Analytical Platform” 

Additional presentations given by UPDDI members to the MPS World Summit: 

Xia, M, “A Patient-derived iPSC Liver Acinus Microphysiology System is an Innovative Precision Medicine Platform for Optimizing Clinical Trial Design of Nonalcoholic Fatty Liver Disease (NAFLD)”.

Maggiore, J, “The BioSystics Analytics Platform: Today a Comprehensive Analytical Platform Creating Actionable Knowledge from in vitro Models, Clinical and Preclinical Data and Soon a Platform to Create Patient Digital Twins”.  

Aleman, J, ”A Microphysiological System Coupling of Metabolic Associated Fatty Liver Disease (MAFLD) to Endocrine Pancreatic Islets”.